7-66089678-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_000048.4(ASL):c.1045G>T(p.Val349Phe) variant causes a missense change. The variant allele was found at a frequency of 0.00000137 in 1,461,248 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_000048.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ASL | NM_000048.4 | c.1045G>T | p.Val349Phe | missense_variant | Exon 14 of 17 | ENST00000304874.14 | NP_000039.2 | |
ASL | NM_001024943.2 | c.1045G>T | p.Val349Phe | missense_variant | Exon 13 of 16 | NP_001020114.1 | ||
ASL | NM_001024944.2 | c.985G>T | p.Val329Phe | missense_variant | Exon 12 of 15 | NP_001020115.1 | ||
ASL | NM_001024946.2 | c.967G>T | p.Val323Phe | missense_variant | Exon 12 of 15 | NP_001020117.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ASL | ENST00000304874.14 | c.1045G>T | p.Val349Phe | missense_variant | Exon 14 of 17 | 1 | NM_000048.4 | ENSP00000307188.9 | ||
ENSG00000249319 | ENST00000450043.2 | c.358G>T | p.Val120Phe | missense_variant | Exon 5 of 12 | 5 | ENSP00000396527.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461248Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 726936
GnomAD4 genome Cov.: 32
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.